The healthcare landscape is evolving, and the financial burden on employers and employees alike is a pressing concern. According to recent data from Mercer, health benefit costs are projected to surge by 6.7% in 2026, surpassing the $18,500 mark per employee. This alarming trend highlights the ongoing challenge of rising healthcare expenses and the need for innovative solutions.
This isn't a new phenomenon, but the magnitude of the problem is undeniable. In 2025, costs rose by 6%, and the pressure on benefit budgets is only intensifying. John Tournet, CEO of Gallagher's benefits and HR consulting division, bluntly states that the current situation is "unsustainable." The "old ways" of simply raising premiums and deductibles are no longer viable.
Employers are feeling the heat, and their response is multifaceted. A staggering 66% of employers with over 500 employees plan to raise premiums in 2026, while half intend to increase cost-sharing through measures like higher deductibles and out-of-pocket maximums. However, this approach is not without its limitations.
Recognizing the need for a more sustainable approach, employers are exploring alternative strategies. Simon Camaj, Mercer's U.S. Health Leader, emphasizes the importance of affordability for employees. This shift in focus is evident in the emergence of non-traditional medical plans. Nearly a third of large employers are offering or considering high-performance networks or variable copay plans, which incentivize employees to utilize cost-effective providers.
One area of cost-saving innovation is GLP-1 coverage. These drugs, often prescribed for weight loss, are expensive. Mercer's data reveals a concerning trend: 6% of large employers have dropped GLP-1 coverage entirely, and another 5% are considering a similar move. This decision reflects a rational approach to cost management, as employers carefully evaluate the value proposition of these medications.
The SHRM Employee Benefits Survey further underscores the evolving landscape of prescription drug coverage. A significant decline in bundled prescription drug coverage with health insurance is observed, while the adoption of independent pharmacy management programs is on the rise. This shift indicates a growing emphasis on managing prescription drug costs through greater control over utilization and access to high-cost medications.
In conclusion, the healthcare industry is at a critical juncture. Rising costs demand a reevaluation of traditional practices. Employers are embracing a multi-pronged approach, combining cost-sharing tactics with innovative strategies. While the challenge remains daunting, the search for sustainable solutions is a testament to the industry's resilience and adaptability.
